133 related articles for article (PubMed ID: 3804520)
1. Evaluation of the absorption from three ibuprofen formulations.
Regazzi BM; Rondanelli R; Ciaroelli L; Bartoli AL; Rampini A
Int J Clin Pharmacol Res; 1986; 6(6):469-73. PubMed ID: 3804520
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules.
Walter K; Weiss G; Laicher A; Stanislaus F
Arzneimittelforschung; 1995 Aug; 45(8):886-90. PubMed ID: 7575754
[TBL] [Abstract][Full Text] [Related]
3. [Bioavailability of a delayed-action aminophylline preparation].
Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
[TBL] [Abstract][Full Text] [Related]
4. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
Pargal A; Kelkar MG; Nayak PJ
Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
[TBL] [Abstract][Full Text] [Related]
5. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules.
Michos N; Zulliger HW; Barkworth MF; Johnson KJ; Rehm KD; Töberich H; Klein G
Arzneimittelforschung; 1986 Jun; 36(6):941-8. PubMed ID: 3741528
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
7. Comparative bioavailability study of two oral formulations of ibuprofen.
Corpetti G; Rosignoli MT; Dionisio P
Arzneimittelforschung; 1998 Apr; 48(4):392-5. PubMed ID: 9608882
[TBL] [Abstract][Full Text] [Related]
8. Common cold and influenza symptom management: the use of pharmacokinetic considerations to predict the efficacy of a twice-daily treatment for colds and flu.
Stillings M; Little S; Sykes J
Curr Med Res Opin; 2003; 19(8):791-9. PubMed ID: 14687451
[TBL] [Abstract][Full Text] [Related]
9. Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers.
Saano V; Paronen P; Peura P; Vidgren M
Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):381-5. PubMed ID: 1748537
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of sustained-release theophylline formulations.
Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D
Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
[TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
Tompson DJ; Vearer D
Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of two new oral formulations of ibuprofen.
Benvenuti C; Cancellieri V; Gambaro V; Lodi F; Marozzi E; Scaroni C
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):308-12. PubMed ID: 3733280
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
15. Single dose absorption profiles and bioavailability of two different salbutamol tablets.
Jonkman JH; Freie HM; van der Boon WJ; Grasmeijer G
Arzneimittelforschung; 1986 Jul; 36(7):1133-5. PubMed ID: 3768084
[TBL] [Abstract][Full Text] [Related]
16. Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man.
Sharma PL; Sharma RM
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):394-6. PubMed ID: 583044
[TBL] [Abstract][Full Text] [Related]
17. Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications.
Dutta S; Reed RC; O'Dea RF
Ann Pharmacother; 2006 Apr; 40(4):619-25. PubMed ID: 16569797
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption of ibuprofen from different formulations. Comparative study with gel, hydrophilic ointment and emulsion cream.
Seth PL
Arzneimittelforschung; 1993 Aug; 43(8):919-21. PubMed ID: 8216453
[TBL] [Abstract][Full Text] [Related]
19. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium.
Suleiman MS; Najib N; el-Sayed Y; Hasan M; Abdulahameed M
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):276-9. PubMed ID: 2737796
[TBL] [Abstract][Full Text] [Related]
20. The influence of food and repeated dosing on the bioavailability of indomethacin from a multiple-units controlled-release formulation.
Skinhøj A; Bechgaard H; Chasseaud LF; Brodie RR; Sharman JM; Taylor T; Hunter JO
Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):557-61. PubMed ID: 6511132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
